Bladder carcinoma cell lines as models of the pathobiology of bladder cancer. Review of the literature and establishment of a new progression series;Harnblasenkarzinomzelllinien als modellsysteme zur pathobiologie des harnblasenkarzinoms. Überblick und etablierung einer neuen progressionsserie

Urologe - Ausgabe A

Volumn 47, Issue 6, 2008, Pages 724-734

  Hatina, J ^a,c   Huckenbeck, W ^a   Rieder, H ^a   Seifert, H H ^a,b   Schulz, W A ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

BFTC 905 progression series; Bladder carcinoma cell lines; Metastatic spread; Pathobiology of bladder cancer; Progression series

Indexed keywords

AGAR; UVOMORULIN;

ARTICLE; BLADDER CARCINOMA; CANCER GROWTH; CELL ADHESION; CELL CULTURE; CELL GROWTH; CELL INVASION; CELL MEMBRANE; CELL STRUCTURE; CHROMOSOME NUMBER; DAUGHTER CELL; HUMAN; HUMAN CELL; KARYOTYPING; METASTASIS; MOLECULAR GENETICS; PROTEIN EXPRESSION; TUMOR CELL LINE;

CELL LINE, TUMOR; HUMANS; URINARY BLADDER NEOPLASMS;

EID: 49949152629     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-008-1687-4     Document Type: Article

References (50)

1. Baak JP, Bol MG, Diermen B van et al. (2003) DNA cytometric features in biopsies of TaT1 urothelial cell cancer predict recurrence and stage progression more accurately than stage, grade, or treatment modality. Urology 61: 1266-1272
2. Bindels EM, Vermey M, Beemd R van den et al. (2000) E-cadherin promotes intraepithelial expansion of bladder carcinoma cells in an in vitro model of carcinoma in situ. Cancer Res 60: 177-183
3. Bindels EM, Vermey M, De Both NJ, Kwast TH van der (2001) Influence of the microenvironment on invasiveness of human bladder carcinoma cell lines. Virchows Arch 439: 552-559
4. Bubenik J, Baresova M, Viklicky V et al. (1973) Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen. Int J Cancer 11: 765-773
5. Byrne RR, Shariat SF, Brown R et al. (2001) E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup. J Urol 165: 1473-1479
6. Chaffer CL, Dopheide B, McCulloch DR et al. (2005) Upregulated MT1-MMP/TIMP-2 axis in the TSU-Pr1-B1/B2 model of metastatic progression in transitional cell carcinoma of the bladder. Clin Exp Metastasis 22: 115-125
7. Chaffer CL, Brennan JP, Slavin JL et al. (2006) Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2. Cancer Res 66: 11271-11278
8. Crallan RA, Georgopoulos NT, Southgate J (2006) Experimental models of human bladder carcinogenesis. Carcinogenesis 27: 374-381
9. Dinney CP, Fishbeck R, Singh RK et al. (1995) Isolation and characterization of metastatic variants from human transitional cell carcinoma passaged by orthotopic implantation in athymic nude mice. J Urol 154: 1532-1538
10. Elliott AY, Cleveland P, Cervenka J et al. (1974) Characterization of a cell line from human transitional cell cancer of the urinary tract. J Natl Cancer Inst 53: 1341-1349
11. Engeler DS, Schmid HP (2003) Das Blasenkarzinom - eine aktuelle Übersicht. Schweiz Rundsch Med Prax 92: 117-126
12. Gildea JJ, Golden WL, Harding MA, Theodorescu D (2000) Genetic and phenotypic changes associated with the acquisition of tumorigenicity in human bladder cancer. Genes Chromosomes Cancer 27: 252-263
13. Gildea JJ, Seraj MJ, Oxford G et al. (2002) RhoGDI2 is an invasion and metastasis suppressor gene in human cancer. Cancer Res 62: 6418-6423
14. Giroldi LA, Bringuier PP, Shimazui T et al. (1999) Changes in cadherin-catenin complexes in the progression of human bladder carcinoma. Int J Cancer 82: 70-76
15. Golka K, Goebell PJ, Rettenmeier AW (2007) Ätiologie und Prävention des Harnblasenkarzinoms. Dtsch Arztebl 104: 719-723
16. Habuchi T (2005) Origin of multifocal carcinomas of the bladder and upper urinary tract: molecular analysis and clinical implications. Int J Urol 12: 709-716
17. Huckenbeck W, Kuntze K, Scheil H-G (1997) The distribution of the human DNA-PCR polymorphisms. Köster, Berlin
18. Jones TD, Wang M, Eble JN et al. (2005) Molecular evidence supporting field effect in urothelial carcinogenesis. Clin Cancer Res 11: 6512-6519
19. Knüchel R, Hofstädter F (1994) In-vitro-Kultur: vom Gewebe zur Zelllinie. Pathologe 15: 141-149
20. Knüchel R, Masters JRW (1999) Bladder cancer. In: Masters JRW, Palsson B (eds) Human cell culture, Vol. 1. Kluwer, Dordrecht, pp 213-230
21. Kovnat A, Buick RN, Choo B et al. (1988) Malignant properties of sublines selected from a human bladder cancer cell line that contains an activated c-Ha-ras oncogene. Cancer Res 48: 4993-5000
22. Li M, Cannizzaro LA (1999) Identical clonal origin of synchronous and metachronous low-grade, noninvasive papillary transitional cell carcinomas of the urinary tract. Hum Pathol 30: 1197-1200
23. Locke M, Heywood M, Fawell S, Mackenzie IC (2005) Retention of intrinsic stem cell hierarchies in carcinoma-derived cell lines. Cancer Res 65: 8944-8950
24. Marshall CJ, Franks LM, Carbonell AW (1977) Markers of neoplastic transformation in epithelial cell lines derived from human carcinomas. J Natl Cancer Inst 58: 1743-1751
25. Masters JR, Hepburn PJ, Walker L et al. (1986) Tissue culture model of transitional cell carcinoma: characterization of twenty-two human urothelial cell lines. Cancer Res 46: 3630-3636
26. Nicholson BE, Frierson HF, Conaway MR et al. (2004) Profiling the evolution of human metastatic bladder cancer. Cancer Res 64: 7813-7821
27. Oliveira PA, Colaco A, De la Cruz PL, Lopes C (2006) Experimental bladder carcinogenesis - rodent models. Exp Oncol 28: 2-11
28. Pagliaro LC, Sharma P (2006) Review of metastatic bladder cancer. Minerva Urol Nefrol 58: 53-71
29. Rebel JM, Thijssen CD, Vermey M et al. (1994) E-cadherin expression determines the mode of replacement of normal urothelium by human bladder carcinoma cells. Cancer Res 54: 5488-5492
30. Sabichi A, Keyhani A, Tanaka N et al. (2006) Characterization of a panel of cell lines derived from urothelial neoplasms: genetic alterations, growth in vivo and the relationship of adenoviral mediated gene transfer to coxsackie adenovirus receptor expression. J Urol 175: 1133-1137
31. Schulz WA (2005) Molecular biology of human cancers. Springer, Dordrecht
32. Schulz WA (2006) Understanding urothelial carcinoma through cancer pathways. Int J Cancer 119: 1513-1518
33. Seifert HH, Meyer A, Cronauer MV et al. (2007) A new and reliable culture system for superficial low-grade urothelial carcinoma of the bladder. World J Urol 25: 297-302
34. Seraj MJ, Harding MA, Gildea JJ et al. (2000) The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines. Clin Exp Metastasis 18: 519-525
35. Stetler-Stevenson WG (2004) Invasion and metastasis. In: DeVita Jr VT, Hellman S, Rosenberg SA (eds) Cancer. Principles and practice of oncology, 7th edn. Lippincott Williams & Wilkins, Philadelphia, pp 113-127
36. Sun W, Herrera GA (2002) E-cadherin expression in urothelial carcinoma in situ, superficial papillary transitional cell carcinoma, and invasive transitional cell carcinoma. Hum Pathol 33: 996-1000
37. Tachibana M, Deguchi N, Baba S et al. (1991) Multivariate analysis of flow cytometric deoxyribonucleic acid parameters and histological features for prognosis of bladder cancer patients. J Urol 146: 1530-1534
38. Tachibana M, Miyakawa A, Miyakawa M et al. (1999) Prognostic significance of flow cytometric deoxyribonucleic acid analysis for patients with superficial bladder cancers: a long-term follow-up study. Cancer Detect Prev 23: 155-162
39. Tsuda H, Fukamachi K, Ohshima Y et al. (2005) High susceptibility of human c-Ha-ras proto-oncogene transgenic rats to carcinogenesis: a cancer-prone animal model. Cancer Sci 96: 309-316
40. Tzeng CC, Liu HS, Li C et al. (1996) Characterization of two urothelium cancer cell lines derived from a blackfoot disease endemic area in Taiwan. Anticancer Res 16: 1797-1804
41. Bokhoven A van, Varella-Garcia M, Korch C, Miller GJ (2001) TSU-Pr1 and JCA-1 cells are derivatives of T24 bladder carcinoma cells and are not of prostatic origin. Cancer Res 61: 6340-6344
42. Wang LH (2004) Molecular signaling regulating anchorage-independent growth of cancer cells. Mt Sinai J Med 71: 361-367
43. Wobus AM (2003) Zellkulturtechniken, Zellmodelle und Tissue Engineering. In: Ganten D, Ruckpaul K (Hrsg) Grundlagen der Molekularen Medizin, 2. Aufl. Springer, Berlin Heidelberg New York, S 255-298
44. Wojcik EM, Brownlie RJ, Bassler TJ, Miller MC (2000) Superficial urothelial (umbrella) cells. A potential cause of abnormal DNA ploidy results in urine specimens. Anal Quant Cytol Histol 22: 411-415
45. Wu X, Obata T, Khan Q et al. (2004) The phosphatidylinositol-3 kinase pathway regulates bladder cancer cell invasion. BJU Int 93: 143-150
46. Wu XR (2005) Urothelial tumorigenesis: a tale of divergent pathways. Nat Rev Cancer 5: 713-725
47. Wu Z, Siadaty MS, Riddick G et al. (2006) A novel method for gene expression mapping of metastatic competence in human bladder cancer. Neoplasia 8: 181-189
48. Zellweger T, Benz G, Cathomas G et al. (2006) Multi-target fluorescence in situ hybridization in bladder washings for prediction of recurrent bladder cancer. Int J Cancer 119: 1660-1665
49. Zhang ZT, Pak J, Shapiro E et al. (1999) Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma. Cancer Res 59: 3512-3517
50. Zhang ZT, Pak J, Huang HY et al. (2001) Role of Ha-ras activation in superficial papillary pathway of urothelial tumor formation. Oncogene 20: 1973-1980